Economic Impact of Converting from Pen and 10-mL Vial to 3-mL Vial for Insulin Delivery in a Hospital Setting

Por Elizabeth, Eby, Smolen, Lee, Pitts, Amber, Krueger, Linda A., Grimm, Doneen
Publicado no Hosp Pharm (2014)

The cost effectiveness of teriparatide as a first-line treatment for glucocorticoid-induced and postmenopausal osteoporosis patients in Sweden

Por Murphy, Daniel R, Smolen, Lee J, Klein, Timothy M, Klein, Robert W
Publicado em 2012

Cost-effectiveness of preventative therapies for postmenopausal women with osteopenia

Por Smolen Lee, Rousculp Matthew D, Klein Robert, Meadows Eric S, Ohsfeldt Robert L, Johnston Joseph A
Publicado em 2007-04-01

Cost-effectiveness of preventative therapies for postmenopausal women with osteopenia

Por Meadows, Eric S, Klein, Robert, Rousculp, Matthew D, Smolen, Lee, Ohsfeldt, Robert L, Johnston, Joseph A
Publicado em 2007

Using Common Random Numbers in Health Care Cost-Effectiveness Simulation Modeling

Por Murphy, Daniel R, Klein, Robert W, Smolen, Lee J, Klein, Timothy M, Roberts, Stephen D
Publicado em 2013

Cost-effectiveness of rosuvastatin in comparison with generic atorvastatin and simvastatin in a Swedish population at high risk of cardiovascular events

Por Gandhi, Sanjay K, Jensen, Marie M, Fox, Kathleen M, Smolen, Lee, Olsson, Anders G, Paulsson, Thomas
Publicado em 2012

Cost-effectiveness model comparing olanzapine and other oral atypical antipsychotics in the treatment of schizophrenia in the United States

Por Furiak, Nicolas M, Ascher-Svanum, Haya, Klein, Robert W, Smolen, Lee J, Lawson, Anthony H, Conley, Robert R, Culler, Steven D
Publicado em 2009